Clinical Prognostic Factors in Breast Cancer

HER-2 LOW NON-METASTATIC BREAST ‎CANCER A CLINICO PATHOLOGICAL STUDY

Clinical outcome of lapatinib and capecitabine in Her-2 +ve advanced/ metastatic breast cancer patients: A prospective study

Prognostic Value of HER2 in Metastatic Colorectal Cancer: A Single Institutional Experience

Clinicopathological Characteristics of Breast Cancer: A local Institutional Experience

Prognostic Factors in Breast Cancer Patients with Brain Metastases: Retrospective Analysis

RETROSPECTIVE STUDY CORRELATING BETWEEN CLINICAL STAGING, PATHOLOGIC STAGING AND MOLECULAR SUBTYPES OF BREAST CANCER

A RETROSPECTIVE ANALYSIS OF CLINICOPATHOLOGICAL DATA AND OUTCOMES OF HORMONAL POSITIVE HER2 NEGATIVE METASTATIC BREAST CANCER PATIENTS IN CLINICAL ONCOLOGY DEPARTMENT IN AIN SHAM

Clinico-Pathological Features of Breast Cancer and Impact on Survival in Elderly Patients

BONE MARROW MICRO-METASTASES IN CLINICALLY STAGE I-III HER2/NEU POSITIVE BREAST CANCER